News

SEARCH FIRM NEWS

news January 27, 2023

Rend Al-Mondhiry Quoted in “Is FDA Watching Heart Health Supplements in 2023?”

Nutritional Outlook spoke with ATW’s Rend Al-Mondhiry about ingredient trends in 2023.

news January 25, 2023

2023 Illinois Edition of Super Lawyers Recognizes Amin Talati Wasserman’s Rising Stars

Two attorneys in the firm were recognized in the latest edition of Illinois Super Lawyers. Kudos to Natascia Taken and Ashley Rovner-Watson. Amin Talati Wasserman is grateful to have these superstars on our team. Natascia Taken: Food & Drugs Ashley Rovner-Watson: Intellectual Property  

news January 6, 2023

Meet the Modernization of Cosmetics Regulation Act of 2022

Once signed into law, the Modernization of Cosmetics Regulations Act of 2022 (MOCRA) will add significant new authorities to chapter VI of the Federal Food, Drug, and Cosmetic Act (FDCA).

news January 3, 2023

Matt Orr Quoted in “Energy Drink Stakeholders Respond to TINA, UConn Rudd Center Complaints”

NutraIngredients-USA asked Matt Orr to comment on complaints by consumer groups over allegations of deceptive and unfair marketing tactics used by the energy drinks industry. Truth in Advertising (TINA) and the UConn Rudd Center for Food Policy & Health focused on “kid-friendly flavors” and packaging tie-ins with candy brands.

news December 12, 2022

Rend Al-Mondhiry Quoted in “Analysis: CBD Food Industry Unlikely to Placate FDA”

Rend Al-Mondhiry spoke with Natural Products Insider about FDA’s recent warning letters to companies regarding CBD in food and offered several key takeaways.

news November 22, 2022

Online Webinar Now Available: “Advertising to an Aging Population”

Seniors are a powerful consumer demographic who want advertising they can believe and content backed by evidence.

news November 22, 2022

Abhishek Gurnani Quoted in “FDA Warning Letters Target Claims to Treat Cardiovascular Disease with Supplements”

Abhishek Gurnani spoke with Natural Products Insider about FDA’s warning to companies that sell dietary supplements claiming to cure, mitigate, treat or prevent cardiovascular disease.

news November 17, 2022

Ivan Wasserman Quoted in “FDA’s Take Down of NMN Raises Fairness, Transparency Concerns”

Ivan Wasserman discussed the FDA’s recent decision that NMN is not a lawful dietary ingredient with Nutraingredients-USA. As reported, the development further complicates the decision to develop an NDI dossier and is part of an increasingly hard line stance by the Agency on the drug exclusion question.

What's Now

Ivan Wasserman Quoted in “FDA Shakeup: Makary Steps Down, Diamantas Steps Up”

In its coverage of the leadership shakeup at FDA and the appointment of a new commissioner, NutraIngredients turned to Ivan Wasserman for comment.

see all news >